Within3, the company that operates insights management for life sciences, unveiled Launch Intelligence™, supported by Know Everything™, revolutionizing next chapter in how life sciences teams make major decisions. By unifying fragmented data into a single, real-time market view, Launch Intelligence™ ensures teams can act with clarity in an environment where product launches carry enormous cost and risk.
Pharmaceutical organizations face a growing challenge: mountains of disconnected data across field activity, HCP engagement, congress sentiment, claims, publications, and social channels. Without a way to connect these signals, major decisions are often delayed or made on incomplete information.
Key Benefits of Launch Intelligence™ are as follows:
- Real-time market understanding: A single, overall view across the most critical data sources.
- Faster, as well as smarter knowledge: AI provides answers in minutes, giving confident decisions during critical times.
- More than a platform: Proprietary advanced technology combined with expert services enables maximum value as well as measurable impact.
Research shows that one-third of drug launches fail to meet market expectations, most often due to gaps in market access and product differentiation. This highlights the urgent need for better launch intelligence along with connected decision-making.
Executive Statement
According to Lance Hill, CEO of Within3, drug development teams should never miss targets due to an inadequate understanding of the market. With the of Launch Intelligence™, their customers can transform solid data into real-time clarity so they can move at the speed of launch, align smarter across teams, and make confident decisions.
